Ionizing radiation induces prostate cancer neuroendocrine differentiation through interplay of CREB and ATF2: implications for disease progression.
about
Wnt-11 promotes neuroendocrine-like differentiation, survival and migration of prostate cancer cellsPKCε promotes oncogenic functions of ATF2 in the nucleus while blocking its apoptotic function at mitochondriaSiah2-dependent concerted activity of HIF and FoxA2 regulates formation of neuroendocrine phenotype and neuroendocrine prostate tumorsNeuroendocrine differentiation in prostate cancerMechanistic Insights into Molecular Targeting and Combined Modality Therapy for Aggressive, Localized Prostate CancerNeuroendocrine differentiation in prostate cancer: a mechanism of radioresistance and treatment failureThe many faces of neuroendocrine differentiation in prostate cancer progressionControl of CREB expression in tumors: from molecular mechanisms and signal transduction pathways to therapeutic targetβ-Adrenergic Receptor Signaling in Prostate CancerPrognostic role of neuroendocrine differentiation in prostate cancer, putting together the pieces of the puzzle.Regulation of Cancer Cell Responsiveness to Ionizing Radiation Treatment by Cyclic AMP Response Element Binding Nuclear Transcription Factor.Emerging roles of ATF2 and the dynamic AP1 network in cancer.Activating transcription factor 2 (ATF2) controls tolfenamic acid-induced ATF3 expression via MAP kinase pathways.Targeting CREB for cancer therapy: friend or foeA Role for OCT4 in Tumor Initiation of Drug-Resistant Prostate Cancer CellsFunctional cyclic AMP response element in the breast cancer resistance protein (BCRP/ABCG2) promoter modulates epidermal growth factor receptor pathway- or androgen withdrawal-mediated BCRP/ABCG2 transcription in human cancer cells.Prostate cancer and neuroendocrine differentiation: more neuronal, less endocrine?Bim and VDAC1 are hierarchically essential for mitochondrial ATF2 mediated cell deathIonizing radiation induces neuroendocrine differentiation of prostate cancer cells in vitro, in vivo and in prostate cancer patientsCritical role of N-terminal end-localized nuclear export signal in regulation of activating transcription factor 2 (ATF2) subcellular localization and transcriptional activity.GSK-3α Is a Novel Target of CREB and CREB-GSK-3α Signaling Participates in Cell Viability in Lung Cancer.ATF2 - at the crossroad of nuclear and cytosolic functions.Co-clustering phenome-genome for phenotype classification and disease gene discovery.Mitochondrial ATF2 translocation contributes to apoptosis induction and BRAF inhibitor resistance in melanoma through the interaction of Bim with VDAC1.Fractionated radiation exposure amplifies the radioresistant nature of prostate cancer cells.Celastrol potentiates radiotherapy by impairment of DNA damage processing in human prostate cancer.GRK3 is a direct target of CREB activation and regulates neuroendocrine differentiation of prostate cancer cells.Hypoxia-mediated alterations and their role in the HER-2/neuregulated CREB status and localization.Redox-mediated and ionizing-radiation-induced inflammatory mediators in prostate cancer development and treatment.Exploring the FGFR3-related oncogenic mechanism in bladder cancer using bioinformatics strategy.The Siah2-HIF-FoxA2 axis in prostate cancer – new markers and therapeutic opportunities.Small cell carcinoma of the prostate after high-dose-rate brachytherapy for low-risk prostatic adenocarcinoma.Leading causes of castration-resistant prostate cancer.Neuroendocrine tumours in rare sites: differences in nomenclature and diagnostics-a rare and ubiquitous histotype.The E3 ubiquitin ligase CHIP mediates ubiquitination and proteasomal degradation of PRMT5.Emerging trends in the evaluation and management of small cell prostate cancer: a clinical and molecular perspective.Transcriptional activation of PRMT5 by NF-Y is required for cell growth and negatively regulated by the PKC/c-Fos signaling in prostate cancer cells.The role of high cell density in the promotion of neuroendocrine transdifferentiation of prostate cancer cells.Cross modulation between the androgen receptor axis and protocadherin-PC in mediating neuroendocrine transdifferentiation and therapeutic resistance of prostate cancer.ATF2, a paradigm of the multifaceted regulation of transcription factors in biology and disease.
P2860
Q24302096-F835AB87-D2EA-4307-A1B4-2F7D29523376Q24304390-88780BD5-6F64-425E-9C11-AD6B25F30BB9Q24337932-AE0971DD-C311-49C5-9026-D776ECE2D0AEQ24657547-2B575444-B0B4-494B-9031-F3BE5FCC4E6AQ26766638-4BFB737F-D7BB-4B44-9958-EBCD9B171364Q26859201-CB5DB3CF-2E92-4E9B-9914-09A5AF0CF61AQ26992049-3D504D87-F243-4FC8-8A2B-3321DB813B69Q28070887-B792998A-3831-48D2-91AF-DCFE72EE1B94Q28084943-8B68A720-EAA3-4F8D-983E-E1C8A0D2A836Q33356928-8D439A83-1D5C-4C55-BA29-EB824F5D280EQ33639047-48155006-ABCA-4D34-804C-829194A7A28FQ33866973-FE07BB55-9C3F-4365-9B74-268963D03032Q34134339-0CA7FA65-D02E-405A-8EE2-C36447D0C0A3Q34387213-149FB22F-BF4D-4665-BE39-9BB8EE1545DFQ34972581-945DDF62-DB8C-4664-BCBA-4B87ACE9677EQ35108153-6AAEC306-25EF-4759-829A-735218EAC358Q35141115-73E2B08B-AE77-474B-A1A8-DCE94803B034Q35293180-403786D5-9A3D-4DA7-B3AF-3BC334119296Q35380936-85258790-087F-4B26-B343-CD06AA60ED9DQ35868135-FB645C6D-EA93-4D79-8F26-93B44C6DCE44Q35980822-79D83738-6A1C-4C48-B390-1E2D8923254EQ36211955-9F8D17F0-087A-4BB4-923E-E2F4AD76B9BDQ36341451-2D74CC58-C9B5-4D29-BFC1-1C730A305298Q36546659-019F1C1D-A69C-4695-B0AE-B5492CDFA334Q37310865-2F974B4B-74A9-4A8D-B181-89756190F38BQ37349650-D051ACCA-57CB-407F-BDB2-8F15DA4558EFQ37564369-294C7AB5-4E83-42A8-AA09-6EBD14B575E8Q37588413-92A826A3-554D-4269-9FC2-92C61681FCF2Q37606662-5D4B6014-44B9-4FFF-BE1B-55D48F5E8BD6Q37713409-385FCB40-7BD1-4473-BB9F-D5E33793E3C9Q37805340-3E2BA3A5-A964-4F82-BA4E-2A7B86FBE9A4Q38068866-D4063FAB-07B9-467B-936B-75FFACA5C816Q38341864-A1399771-71D7-41AB-B884-64AC97C85D89Q38750084-BA5500E7-077A-4880-BC39-0CD140F2C218Q38812367-6E98364F-43EE-48D2-9B92-02C63C743A80Q38930155-7128C2C8-7185-4D5C-9F96-BE63A62209F7Q38950645-E8BC0F2E-2A7A-4FE4-A640-F9B96172F431Q38989505-B54C0BC2-AD47-499E-BEBA-2181C592BDB0Q39132563-47AF7AD2-D1F9-4378-8C82-8DB9D98788D0Q39141159-6F581219-689A-4482-A844-955D92A7E1BA
P2860
Ionizing radiation induces prostate cancer neuroendocrine differentiation through interplay of CREB and ATF2: implications for disease progression.
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Ionizing radiation induces pro ...... tions for disease progression.
@ast
Ionizing radiation induces pro ...... tions for disease progression.
@en
type
label
Ionizing radiation induces pro ...... tions for disease progression.
@ast
Ionizing radiation induces pro ...... tions for disease progression.
@en
prefLabel
Ionizing radiation induces pro ...... tions for disease progression.
@ast
Ionizing radiation induces pro ...... tions for disease progression.
@en
P2093
P2860
P1433
P1476
Ionizing radiation induces pro ...... tions for disease progression.
@en
P2093
Chang-Deng Hu
Evan T Keller
Jiaoti Huang
Liang Cheng
Sarah J Parsons
Xuehong Deng
P2860
P304
P356
10.1158/0008-5472.CAN-08-2229
P407
P577
2008-12-01T00:00:00Z